COVID-19

AMA Update 108: Sandra Fryhofer, MD, discusses new J&J vaccine recommendations

AMA CXO Todd Unger talks with Sandra Fryhofer, MD, the AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and chair-elect of the AMA Board of Trustees about updated vaccine recommendations based on an increased, but still rare, risk of thrombosis with thrombocytopenia with the Johnson & Johnson vaccine. Also, covering the latest on Omicron and vaccine effectiveness, a vaccine safety update for children aged 5-11 and the status of a COVID vaccine for toddlers.

Read More

AMA Update 105: Andrea Garcia, JD, MPH, discusses the spread of the Omicron variant

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of Omicron across the U.S. and globally, as well as New York City’s vaccine mandate for private employees.

Read More

AMA Update 103: Andrea Garcia, JD, MPH, discusses omicron, vaccine mandate challenges and Merck’s COVID pill

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the omicron variant, vaccine mandate challenges and pending FDA authorization for Merck’s COVID pill.

Read More

AMA Update 102: Paul Offit, MD, discusses the importance of pediatric COVID vaccination

AMA CXO Todd Unger talks with Paul Offit, MD, the director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia, about pediatric COVID vaccination, mandates and boosters.

Read More

AMA Update 101: Andrea Garcia, JD, MPH, discusses uptick in COVID cases and flu outbreaks

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on COVID-19 treatment pills, expanding eligibility for booster shots, what the uptick in cases in Europe could forecast for the U.S., as well as flu outbreaks and press releases from the November 2021 Special Meeting of the AMA House of Delegates.

Read More

AMA Update 99: Andrea Garcia, JD, MPH, discusses legal challenges to Biden’s vaccine requirements

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering legal challenges to the Biden administration’s recent vaccine requirements for large companies and health workers, as well as ongoing efforts to vaccinate the nation’s 5 to 11 year olds.

Read More

AMA Update 97: Andrea Garcia, JD, MPH, discusses recent EUA for Pfizer’s COVID vaccine for 5-11 year olds

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA’s authorization of Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, vaccine mandates in schools, and the AMA’s support of the Biden Administration’s plan to address the nation’s overdose epidemic.

Read More

AMA Update 96: Dr. Aaron Carroll talks Halloween and holidays and how to assess risk

AMA CXO Todd Unger discusses Halloween and assessing risk heading into the holiday season with Dr. Aaron Carroll, a professor of pediatrics and chief health officer at Indiana University. 

Read More

AMA Update 95: Andrea Garcia, JD, MPH, discusses vaccine authorization for 5-11 year olds

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster news and current vaccine timeline for the 5 to 11 year old age group.

Read More

AMA Update 94: Dr. Sandra Fryhofer shares the latest on boosters and the new «mix-and-match strategy»

AMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

Read More